Álvaro Teijeira

22PUBLICATIONS
136CO-AUTHORS
Molecular targetsInformation systems philosophy, research methods and theoryCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imagingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 03, 2026
Complement-driven NETosis mediates immunotherapy resistance in STK11-mutant lung adenocarcinoma.

|Oct 12, 2026
Launching an independent research laboratory and scientific career: Tools for a rapidly changing landscape.

|Sep 07, 2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

|Aug 06, 2026
Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

|Jul 25, 2026
A Lightweight, 3D-Printable, Low-Cost, "One-Click" Dorsal Skin Window for High-Quality Long-Term Multimodal Subcutaneous Tumor Imaging.

|Feb 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio

Pageof 4

Frequent Collaborators

16 joint publications

Ignacio Melero

13 joint publications

Pedro Berraondo

8 joint publications

Carlos E de Andrea

7 joint publications

Carlos Luri-Rey